16
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Hematopoietic Stem Cell Transplantation in Adult Acute Lymphoblastic Leukemia: a Single-Centre Analysis

, , , , , & show all
Pages 1175-1180 | Received 14 Oct 2003, Published online: 03 Aug 2009

Reference

  • Parker, S.L., Tong, T., Bolden, S. and Wingo, P.A. (1997) "Cancer statistics", CA Cancer Journal for Clinicians, 47, 5–27.
  • Pui, C.-H. and Evans, W.E. (1998) "Acute Lymphoblastic Leukemia", New England Journal of Medicine, 339, 605 — 615.
  • Cortes, J.E. and Kantarjian, H.M. (1995) "Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy", Cancer, 76, 2393–2417.
  • Hoelzer, D., Thiel, E., Ludwig, W.D., et al. (1993) "Follow-up of the first two successive German multicentre trials for adult ALL (01/ 81 and 02/84). German Adult ALL Study Group", Leukemia, 7\(suppl 2), 130–134.
  • Annino, L., Vegna, ML., Camera, A., et al. (2000) "Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study", Blood, 99, 863 — 871.
  • Dekker, A.W., van't Veer, MB., Sizoo, W., et al. (1997) "Intensive postremission therapy chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Dutch Hematology-Oncology Research group", Journal Clinical Oncology, 15, 476–482.
  • Durrant, U., Richards, S.M., Prentice, G.H., et al. (1997) "The Medical Research Council Trial in Adult Acute Lymphoblastic Leukemia", Hematology/Oncology Clinics of North America, 14, 1327 — 1352.
  • Bassan, R., Pogliani, E., Casula, P., et al. (2001) "Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem-cell transplantation in high-risk groups", Hematology Journal, 2, 117 — 126.
  • Sebban, C., Lepade, E., Vernant, J.P., et al. (1994) "Allogeneic Bone Marrow Transplantation in Adult Acute Lymphoblastic Leukemia in First Complete Remission: A comparative study", Journal of Clinical Oncology, 12, 2580–2587.
  • Rowe, J.M. (1999) "Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL) in first complete remission (CR): Early results from the international ALL trial (MRC UKALL/ECOG E2993)", Blood, 94, 732a.
  • Ringden, 0., Labopin, M., Gorin, N.C., et al. (2000) "Is there a graft-versus-leukemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukemia?", British Journal of Haematology, 111, 1130–1137.
  • Zykos, P., Van Lint, M.T., Lamparelli, T., et al. (1998) "Allogeneic hematopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse", Haematologica, 83, 896— 903.
  • Zhang, M.J., Hoelzer, D., Horowitz, M., et al. (1995) "Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplanta-tion. The Acute Lymphoblastic Leukemia Working Committee", Annals of Internal Medicine, 123, 428–431.
  • Wingard, J.R., Piantadosi, S., Santos, G.W., et al. (1990) Allogeneic bone marrow transplantation for patients with high-risk acute lyphoblastic leukemia", Journal of Clinical Oncology, 8, 820–830.
  • Barret, A.J., Horowitz, MM., Ash, R.C., et al. (1992) "Bone Marrow Transplantation for Philadelphia Chromosome-Positive Lymphoblastic Leukemia", Blood, 79, 3067 — 3070.
  • Chao, N.J., Forman, S.J., Schmidt, G.M., et al. (1991) "Allogeneic Bone Marrow Transplantation for High-Risk Acute Lymphoblastic Leukemia During First Complete Remission", Blood, 78, 1923 — 1927.
  • Linker, CA. (1997) "Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL)", Leukemia, 11\(suppl 4), 24–27.
  • Wetzler, M., Dodge, R.K., MrOzek, K., et al. (1999) "Prospective Karyotype Analysis In Adult Acute Lymphoblastic Leukemia: the Cancer and Leukemia Group B Experience", Blood, 93, 3983–3993.
  • Larson, R.A., Dodge, R.K., Bloomfield, C.D., et al. (1997) Treatment of biologically determined subsets of acute lymphoblastic leukemia in adults: Cancer and Leukemia Group B studies. In Acute Leukemias VI. Prognostic Factors and Treatment Strategies, edited by T. Buchner, W. Hiddermann, B. Wörmann, J. Ritter and G. Schellong. P. 677. Berlin: Springer-Verlag.
  • Hoelzer, D., Thiel, E., Loffler, H., et al. (1988) "Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults", Blood, 71, 123— 131.
  • Fière, D., Lepage, E., Sebban, C., et al. (1990 & 1993) "Adult Acute Lymphoblastic Leukemia: A Multicentric Randomized Trial Test-ing Bone Marrow Transplantation as Postremission Therapy", Journal of Clinical Oncology, 11, 1990–2001.
  • McMillan, AK., Gribben, J.G., Linch, D.C., et al. (1990) "Autologous Bone Marrow Transplantation in Acute Lymphoblas-tic Leukemia: 1980— 1989" Leukemia and Lymphoma, 1, 157–162.
  • Gorin, N.C., Aegerter, P. and Anvert, B. (1990) "Autologous bone marrow transplantation (ABMT) for acute lymphoblastic leuke-mia", Bone Marrow Transplantation, 4\(suppl 2), 3–5.
  • Weisdorf, D.J., Billet, AL., Hannan, P., et al. (1997) "Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia", Blood, 90, 2962–2968.
  • Gökbuget, N. (2001) "Intensification of induction and consolidation improves only subgroups of adult ALL: Analysis of 1200 patients in GMALL study 05/93", Blood, 98, 802a.
  • Forman, S.J.. (1999) "Transplant Approaches to High-Risk ALL", Hematology, 1999, 96— 101.
  • Kolb, H.J., Schattenberg, A., Goldman, J.M., et al. (1995) "Graft-versus leukemia effect of donor lymphocyte trasfusion in marrow grafted patients. European Group for Blood and Marrow Trans-plantation Working Party Chronic Leukemia", Blood, 86, 2041–2050.
  • Collins, R.H., Jr, Shpilberg, 0., Drobyski, W.R., et al. (1997) "Donor leukocytes infusion in 140 patients with relapsed malignant after allogeneic bone marrow transplantation", Journal of Clinical Oncology, 15, 433–444.
  • Martin, T.G. and Linker, CA. (2001) "Autologous stem cell transplantation for acute lymphocytic leukemia in adults", Hema-tology/Oncology Clinics of North America, 15, 121–143.
  • Kernan, R.A., Bartsch, G., Ash, R.C., et al. (1993) "Analysis of 462 transplantation form unrelated donor facilitated by the National Marrow Donor Program" New England Journal of Medicine, 328, 539— 602.
  • Szydlo, R., Goldman, J.M., Klein, J.P., et al. (1997) "Results of allogeneic bone marrow transplantation for acute leukemia using donors other than HLA-identical siblings", Journal of Clinical Oncology, 15, 1767 — 1777.
  • Thiebault, A., Vernant, J.P., Degos, L., et al. (2000) "Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87", Hematology/Oncology Clinics of North America, 14, 1353— 1366.
  • Dazzi, F., Szydlo, R.M., Cross, N.C., et al. (2000) "Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukaemia", Blood, 96, 2712–2716.
  • Buckner, C.D., Sanders, J.E., Hill, R., et al. (1989) "Allogeneic versus autologous marrow transplantation for patients with acute lymphoblastic leukemia in first or second marrow remission". In Autologous Bone Marrow Transplant Proceedings of the Fourth International Symposium, edited by K.A. Dicke, G. Spitzer, S. Jagannath and M.J. Evinger-Hodges. Pp. 145–149. Houston: The University of Texas, M.D. Anderson Cancer Center.
  • Kersey, J.H., Weisdorf, D., Nesbit, ME., et al. (1987) "Autologous BMT for patients with acute lymphoblastic leukemia", New England Journal of Medicine, 317, 461 —467.
  • Rizzoli, V., Mangoni, L., Carella, AM., et al. (1989) "Drug-mediated marrow purging: maphosphamide in adult acute leukemia in remission. The experience of the Italian Study Group", Bone Marrow Transplantation, 4\(suppl 1), 190–194.
  • Simonsson, B., Burnett, AK., Prentice, HG., et al. (1989) "Autologous bone marrow transplantation with monoclonal anti-bodies purged marrow for high-risk acute lymphoblastic leukae-mia", Leukemia, 3, 631 — 636.
  • Proctor, S.J., Hamilton, PG., Taylor, P., et al. (1988) "A comparative study of combination chemotherapy versus marrow transplantation in first remission in adult acute lymphoblastic leukemia", British Journal of Haematology, 69, 35–39.
  • Mortuza, F.Y., Papaioannou, M., Moreira, I.M., et al. (2000) "Minimal residual disease test provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia", Journal of Clinical Oncology, 20, 1094 — 1104.
  • Radich, J., Gehly, G., Lee, A., et al. (1997) "Detection of bcr-abl Transcripts in Philadelphia Chromosome Positive Acute Lympho-blastic Leukemia After Marrow Transplantation", Blood, 89, 2602 — 2609.
  • Ramsay, N., LeBien, T., Weisdorf, D., et al. (1989) "Autologous BMT for patients with acute lymphoblastic leukaemia". In Bone Marrow Transplantation. Current controversies, edited by R.P. Gale and RE. Champlin. Pp. 57 — 66. New York: Alan R. Liss, Inc.
  • Egerer, G., Goldschmidt, H., Zoz, M. and Ho, AD. (2003) "Autologous Bone Marrow Transplantation in Adult Patients with Acute Lymphoblastic Leukemia", Leukemia and Lymphoma, 44, 9 — 14.
  • Lambertenghi Deliliers, G., Mozzana, R., Butti, C., et al. (1993) "Long-Term Results of Autologous Bone Marrow Transplantation in Adult Acute Lymphoblastic Leukemia", Leukemia and Lympho-ma, 11, 419–425.
  • Grigg, A.P., Szer, J., Beresford, J., et al. (1999) "Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia". British Journal of Haematology, 107, 409–418.
  • Herzig, R.H., Bortin, MM., Barrett, A.J., et al. (1987) "Bone-marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second complete remission", Lancet, 1, 786–789.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.